Related Experiment Video
Updated: Jun 21, 2026

09:35
Attaching Biological Probes to Silica Optical Biosensors Using Silane Coupling Agents
Published on: May 1, 2012
13.0K
Advancements and Perspectives in Optical Biosensors
Shahriar Mostufa1, Bahareh Rezaei1, Stefano Ciannella2
1Department of Electrical and Computer Engineering, Texas Tech University, Lubbock, Texas 79409, United States.
ACS Omega
|June 17, 2024
Summary
Optical biosensors offer sensitive, rapid, and reusable detection for diagnostics. This review highlights plasmonic and metasurface biosensors as promising for lab-on-chip and point-of-care applications.
Area of Science:
- Biomedical Engineering
- Optoelectronics
- Nanotechnology
Background:
- Optical biosensors provide high sensitivity, reusability, and rapid detection capabilities for biosensing.
- Advancements in optical biosensor platforms are crucial for developing next-generation diagnostic tools.
- Plasmonic and metasurface-based biosensors show significant promise for bioassays.
Purpose of the Study:
- To provide a concise overview of optical biosensors, including platforms, mechanisms, and physics.
- To summarize recent advancements in optical biosensing technologies.
- To discuss the potential of optical biosensors for lab-on-chip and point-of-care devices.
Main Methods:
- Review of existing literature on optical biosensor platforms.
- Focus on plasmonic biosensors (SPR, LSPR, SERS) and metasurface-based biosensors.
- Analysis of operational mechanisms, underlying physics, and performance in bioassays.
Main Results:
- Optical biosensors offer superior sensitivity, reusability, and speed compared to traditional methods.
- Plasmonic biosensors (SPR, LSPR, SERS) demonstrate versatility for diverse bioassays.
- Metasurface-based biosensors are emerging as powerful tools for advanced biosensing.
Conclusions:
- Optical biosensors, particularly plasmonic and metasurface types, are excellent candidates for lab-on-chip and point-of-care devices.
- Continued advancements position optical biosensors as a robust platform for early disease diagnostics.
- Addressing current challenges will further accelerate the adoption of optical biosensing technologies.

